Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
This activity is hosted on GeneTherapy.ISTH.org. By clicking Begin Activity, you will be leaving The France Foundation website.
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA